BlackRock’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.71M Buy
1,172,441
+224,079
+24% +$518K ﹤0.01% 3911
2025
Q1
$7.41M Sell
948,362
-41,196
-4% -$322K ﹤0.01% 3429
2024
Q4
$4.62M Buy
989,558
+50,090
+5% +$234K ﹤0.01% 3711
2024
Q3
$5.06M Buy
939,468
+126,573
+16% +$682K ﹤0.01% 3645
2024
Q2
$7.17M Buy
812,895
+572,729
+238% +$5.05M ﹤0.01% 3506
2024
Q1
$2.82M Sell
240,166
-17,763
-7% -$209K ﹤0.01% 3820
2023
Q4
$2.9M Buy
257,929
+25,105
+11% +$283K ﹤0.01% 3824
2023
Q3
$1.58M Sell
232,824
-6,809
-3% -$46.1K ﹤0.01% 4025
2023
Q2
$2.18M Buy
239,633
+4,909
+2% +$44.6K ﹤0.01% 3938
2023
Q1
$1.52M Sell
234,724
-601
-0.3% -$3.88K ﹤0.01% 4098
2022
Q4
$1.49M Buy
235,325
+2,082
+0.9% +$13.2K ﹤0.01% 4177
2022
Q3
$1.45M Sell
233,243
-877
-0.4% -$5.43K ﹤0.01% 4258
2022
Q2
$2.07M Buy
234,120
+2,121
+0.9% +$18.7K ﹤0.01% 4157
2022
Q1
$1.95M Sell
231,999
-1,266
-0.5% -$10.7K ﹤0.01% 4322
2021
Q4
$2.38M Buy
233,265
+86,836
+59% +$886K ﹤0.01% 4269
2021
Q3
$2.84M Sell
146,429
-37,577
-20% -$730K ﹤0.01% 4110
2021
Q2
$3.23M Sell
184,006
-35,724
-16% -$628K ﹤0.01% 3999
2021
Q1
$2.61M Buy
219,730
+198,487
+934% +$2.36M ﹤0.01% 4143
2020
Q4
$366K Buy
21,243
+2,854
+16% +$49.2K ﹤0.01% 4313
2020
Q3
$190K Sell
18,389
-413
-2% -$4.27K ﹤0.01% 4317
2020
Q2
$98K Buy
18,802
+3,050
+19% +$15.9K ﹤0.01% 4406
2020
Q1
$52K Buy
15,752
+9,200
+140% +$30.4K ﹤0.01% 4389
2019
Q4
$38K Buy
6,552
+2,597
+66% +$15.1K ﹤0.01% 4510
2019
Q3
$24K Buy
3,955
+907
+30% +$5.5K ﹤0.01% 4572
2019
Q2
$29K Buy
3,048
+2,864
+1,557% +$27.2K ﹤0.01% 4583
2019
Q1
$1K Buy
+184
New +$1K ﹤0.01% 4825